Cell therapy · FDA · US patients · 2030
Customized stem cell therapy for all US patients
A practical knowledge base for patients, clinicians and researchers: what FDA has approved, the evidence behind it, how the rules work, and what it would take to reach every US patient by 2030.
Who are you?
I am one of the
Patients & families
Find out what is proven, what is not, and how to spot an unsafe clinic.
I am one of the
Clinicians
Look up approved products by condition, the evidence behind them, and where to refer.
I am one of the
Researchers & sponsors
Work out your regulatory tier and plan the route to an approved product.
Explore
Successful cases
39 successful cases, from CRISPR-edited stem cells to stem-cell-derived islets, with outcome numbers and sources.
Approved products directory
Search all 55 FDA-approved cellular and gene therapy products.
Regulatory navigator
How FDA regulates cell and tissue products, with a 361 vs 351 self-check.
Verify a clinic
An interactive checklist to tell an FDA-compliant program from an unproven clinic.
Pathways to patients
From preclinical work to IND, expanded access, RMAT and BLA approval.
2030 care-delivery roadmap
A scenario for how approved, customized therapies could reach community settings.